Advances in targeted therapy and immunotherapy for esophageal cancer

Esophageal cancer (EC) is one of the most common aggressive malignant tumors in the digestive system with a severe epidemiological situation and poor prognosis. The early diagnostic rate of EC is low, and most EC patients are diagnosed at an advanced stage. Multiple multimodality treatments have gra...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Haiou, Li, Xuewei, Yang, Wenhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431250/
https://www.ncbi.nlm.nih.gov/pubmed/37403208
http://dx.doi.org/10.1097/CM9.0000000000002768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431250/
https://www.ncbi.nlm.nih.gov/pubmed/37403208
http://dx.doi.org/10.1097/CM9.0000000000002768

Ejemplares similares